Global prevalence of intellectual developmental disorder in dystrophinopathies: A systematic review and meta‐analysis
Developmental Medicine & Child Neurology · 2023-06 · 65 (6) · 734-744
DOI: 10.1111/dmcn.15481 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 28.11.2022. Verfasst von Carlos Pascual-Morena und 6 weiteren Autor:innen. Beteiligte Einrichtung: Health and Social Research Center, Universidad de Castilla-La Mancha, Cuenca, Spain. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Intellectual Disability. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 91 Literaturangaben.
Abstract (Originalsprache)
Aim
To estimate the global prevalence of intellectual developmental disorder (IDD) and the IDD prevalence–genotype association in Becker muscular dystrophy (BMD) or Duchenne muscular dystrophy (DMD) according to the affected isoforms of the DMD gene: Dp427 , Dp140 , Dp71 .
Method
Systematic searches in MEDLINE, Scopus, Web of Science, and the Cochrane Library were conducted from inception of each database to March 2022. Observational studies that determined the prevalence of IDD in the population with BMD or DMD were included. Meta‐analyses of IDD prevalence and prevalence ratios of the IDD–genotype association were conducted.
Results
Forty‐nine studies were included. The prevalence of IDD in BMD was 8.0% (95% confidence interval 5.0–11.0), and in DMD it was 22.0% (18.0–27.0). Meta‐analyses of IDD–genotype association showed a deleterious association between IDD and the number of isoforms affected in DMD, with a prevalence ratio = 0.43 (0.28–0.64) and 0.17 (0.09–0.34) for Dp140 + / Dp71 + versus Dp140 − / Dp71 + and Dp140 + / Dp71 + versus Dp140 − / Dp71 − comparisons respectively. However, in BMD, there was no association for Dp140 + / Dp71 + versus Dp140 − / Dp71 + .
Interpretation
There is a high prevalence of IDD in BMD and DMD. Moreover, the number of isoforms affected is strongly and negatively associated with the prevalence of IDD in DMD. What this paper adds The global prevalence of intellectual developmental disorder (IDD) was 8% in Becker muscular dystrophy and 22% in Duchenne muscular dystrophy (DMD). The global prevalence of IDD in DMD was 12%, 29%, and 84% in participants with Dp427 − / Dp140 + / Dp71 + , Dp427 − / Dp140 − / Dp71 + , and Dp427 − / Dp140 − / Dp71 − genotypes respectively. In DMD, 12% and 22% of participants had abnormal performance IQ and verbal IQ values respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Health and Social Research Center, Universidad de Castilla-La Mancha, Cuenca, Spain.
- Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, Chile.
- Universidad Politécnica y Artística del Paraguay, Asunción, Paraguay.
ORCID-Profile: Carlos Pascual-Morena, Iván Cavero-Redondo, Celia Álvarez-Bueno, Estela Jiménez-López, Alicia Saz-Lara, Irene Martínez-García, Vicente Martínez-Vizcaíno
Zitieren
APA
Pascual-Morena, C., Cavero-Redondo, I., Álvarez-Bueno, C., Jiménez-López, E., Saz-Lara, A., Martínez-García, I., & Martínez-Vizcaíno, V. (2023). Global prevalence of intellectual developmental disorder in dystrophinopathies: A systematic review and meta‐analysis. Developmental Medicine & Child Neurology, 65(6), 734-744. https://doi.org/10.1111/dmcn.15481
Vancouver
Pascual-Morena C, Cavero-Redondo I, Álvarez-Bueno C, Jiménez-López E, Saz-Lara A, Martínez-García I, et al. Global prevalence of intellectual developmental disorder in dystrophinopathies: A systematic review and meta‐analysis. Developmental Medicine & Child Neurology. 2023;65(6):734-744. doi:10.1111/dmcn.15481
BibTeX
@article{PascualMorena2023,
author = {Pascual-Morena, Carlos and Cavero-Redondo, Iván and Álvarez-Bueno, Celia and Jiménez-López, Estela and Saz-Lara, Alicia and Martínez-García, Irene and Martínez-Vizcaíno, Vicente},
title = {Global prevalence of intellectual developmental disorder in dystrophinopathies: A systematic review and meta‐analysis},
journal = {Developmental Medicine & Child Neurology},
year = {2023},
volume = {65},
number = {6},
pages = {734--744},
doi = {10.1111/dmcn.15481}
}
EUVIMED